Order Article Reprints

Alves JDF, Yamaguti A, de Mendonça JS, de Melo Gamba C, Fonseca CL, Paraskevopoulos DKS, de Paula AI, Hosino N, Costa SF, Guimarães T. Metronidazole for Treatment of Clostridioides difficile Infections in Brazil: A Single-Center Experience and Risk Factors for Mortality. Antibiotics. 2022; 11(9):1162. https://doi.org/10.3390/antibiotics11091162

Alves, Joana Darc Freitas, Augusto Yamaguti, João Silva de Mendonça, Cristiano de Melo Gamba, Cibele Lefreve Fonseca, Daniela K. S. Paraskevopoulos, Alexandre Inacio de Paula, Nair Hosino, Silvia Figueiredo Costa, and Thaís Guimarães. 2022. "Metronidazole for Treatment of Clostridioides difficile Infections in Brazil: A Single-Center Experience and Risk Factors for Mortality" Antibiotics 11, no. 9: 1162. https://doi.org/10.3390/antibiotics11091162

Alves, J. D. F., Yamaguti, A., de Mendonça, J. S., de Melo Gamba, C., Fonseca, C. L., Paraskevopoulos, D. K. S., de Paula, A. I., Hosino, N., Costa, S. F., & Guimarães, T. (2022). Metronidazole for Treatment of Clostridioides difficile Infections in Brazil: A Single-Center Experience and Risk Factors for Mortality. Antibiotics, 11(9), 1162. https://doi.org/10.3390/antibiotics11091162